Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1199-1202

  O'Sullivan, Denise M ^a,d   Hinds, J ^b   Butcher, P D ^b   Gillespie, S H ^a,c   McHugh, T D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Gene expression; Mutation; SOS repair

Indexed keywords

BACTERIAL DNA; CIPROFLOXACIN; LEXA PROTEIN; RECA PROTEIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; GENOME ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANTITUBERCULAR AGENTS; CIPROFLOXACIN; DNA REPAIR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOS RESPONSE (GENETICS);

EID: 56649109923     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn387     Document Type: Article

References (23)

1. Fung-Tomc J, Kolek B, Bonner DP. Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37: 1289-96.
2. Gillespie SH, Voelker LL, Ambler JE et al. Fluoroquinolone resistance in Streptococcus pneumoniae: Evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation. Microb Drug Resist 2003; 9: 17-24.
3. Rustomjee R, Lienhardt C, Kanyok T et al. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 12: 128-38.
4. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61: 377-92.
5. Phillips I, Culebras E, Moreno F et al. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987; 20 631-8.
6. Levin DE, Marnett LJ, Ames BN. Spontaneous and mutagen-induced deletions: Mechanistic studies in Salmonella tester strain TA102. Proc Natl Acad Sci USA 1984; 81: 4457-61.
7. Bisognano C, Kelley WL, Estoppey T et al. A RecA- LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus. J Biol Chem 2004; 279: 9064-71.
8. Dong Y, Xu C, Zhao X et al. Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance. Antimicrob Agents Chemother 1998; 42: 2978-84.
9. Moadebi S, Harder CK, Fitzgerald MJ et al. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 2007; 67: 2077-99.
10. Gillespie SH, Basu S, Dickens AL et al. Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 2005; 56: 344-8.
11. Ferrara AM. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection 2005; 33: 106-14.
12. Mangan JA, Monahan IM, Butcher PD. Gene expression during host-pathogen interactions: Approaches to bacterial mRNA extraction and labelling for microarray analysis. In: Wren B, Dorrell N, eds. Functional Microbial Genomics: Methods in Microbiology. London: Academic Press, 2002; 137-51.
13. Boshoff HI, Reed MB, Barry CE III et al. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 2003; 113: 183-93.
14. Brooks PC, Movahedzadeh F, Davis EO. Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: Apparent lack of correlation with LexA binding. J Bacteriol 2001; 183 4459-67.
15. Hampshire T, Soneji S, Bacon J et al. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: A model for persistent organisms? Tuberculosis 2004; 84: 228-38.
16. T method. Methods 2001; 25: 402-8.
17. Kendall SL, Movahedzadeh F, Rison SC et al. The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses. Tuberculosis (Edinb) 2004; 84: 247-55.
18. Mizrahi V, Andersen SJ. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998; 29: 1331-9.
19. Shi L, Sohaskey CD, Kana BD et al. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 2005; 102: 15629-34.
20. Papavinasasundaram KG, Anderson C, Brooks PC et al. Slow induction of RecA by DNA damage in Mycobacterium tuberculosis. Microbiology 2001; 147: 3271-9.
21. Davis EO, Dullaghan EM, Rand L. Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in Mycobacterium tuberculosis. J Bacteriol 2002; 184: 3287-95.
22. Cirz RT, O'Neill BM, Hammond JA et al. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 2006; 188: 7101-10.
23. Drlica K. Biology of bacterial deoxyribonucleic acid topoisomerases. Microbiol Rev 1984; 48: 273-89.